EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Potassium 4‐Methoxysalicylate ( 4MSK ) Exerts a Skin Lightening Effect by Acting on Melanocytes and Keratinocytes

Yutaka Shirasugi iD, Takako Shibata iD, Saaya Koike, Masao Hara iD, Kiyotaka Hasegawa, Masato Iino, Aska Sonoki iD, Yoko Funasaka iD

Journal of Cosmetic Dermatology · 2025

DOI: 10.1111/jocd.70112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Yutaka Shirasugi und 7 weiteren Autor:innen. Beteiligte Einrichtung: MIRAI Technology Institute, Shiseido Co. Ltd., Yokohama, Japan. Hauptthemen laut MEDLINE: Hyperpigmentation, Keratinocytes, Melanocytes, Skin Lightening Preparations. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hyperpigmentation is a common acquired disorder that can be a cosmetic concern for many individuals. To reduce and prevent hyperpigmentation, numerous skin lightening agents have been developed. Potassium 4‐methoxysalicylate (4MSK) is a skin lightening agent that was approved as an active skin lightening ingredient of quasi‐drugs by the Ministry of Health, Labour and Welfare of Japan in 2003. For over 20 years, 4MSK has been widely used in quasi‐drug and cosmetic products. However, the mechanism of action and efficacy of 4MSK on skin pigmentation and skin lightness have not been publicly reported.

Aims

This study aimed to assess the mechanism of action and the efficacy of 4MSK on facial pigmentation.

Methods

The mechanism of action of 4MSK on epidermal cells was investigated using human melanocytes, human keratinocytes, and human 3D epidermal equivalents. The efficacy of 4MSK on facial pigmentation was evaluated by a human clinical study, which is a double‐blind, split‐face, placebo‐controlled, paired‐design study.

Results

4MSK significantly suppressed melanin content in cultured human melanocytes and a 3D epidermal equivalent. It also promoted gene expression of differentiation markers of human keratinocytes. In the clinical study, a 4MSK formulation significantly increased skin lightness values in both pigmented and non‐pigmented areas of cheek skin. In addition, it reduced the desquamation area ratio of the cheek.

Conclusions

4MSK reduces skin pigmentation and contributes to brighter skin by acting on both melanocytes and keratinocytes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperpigmentationKeratinocytesMelanocytesSkin Lightening PreparationsSkin PigmentationAdultFemaleHumansMaleMiddle AgedCell DifferentiationCells, CulturedDouble-Blind MethodFaceMelanins

Stichwörter der Autor:innen

hyperpigmentationkeratinizationmelanogenesispotassium 4‐methoxysalicylateskin lightening

Substanzen

MelaninsSkin Lightening Preparations

Autor:innen und Institutionen

  • MIRAI Technology Institute, Shiseido Co. Ltd., Yokohama, Japan.
  • Department of Dermatology, Ikebukuro West Gate Hospital, Tokyo, Japan.

ORCID-Profile: Yutaka Shirasugi, Takako Shibata, Masao Hara, Aska Sonoki, Yoko Funasaka

Zitieren

APA

Shirasugi, Y., Shibata, T., Koike, S., Hara, M., Hasegawa, K., Iino, M., Sonoki, A., & Funasaka, Y. (2025). Potassium 4‐Methoxysalicylate ( 4MSK ) Exerts a Skin Lightening Effect by Acting on Melanocytes and Keratinocytes. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70112

Vancouver

Shirasugi Y, Shibata T, Koike S, Hara M, Hasegawa K, Iino M, et al. Potassium 4‐Methoxysalicylate ( 4MSK ) Exerts a Skin Lightening Effect by Acting on Melanocytes and Keratinocytes. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70112

BibTeX
@article{Shirasugi2025,
  author = {Shirasugi, Yutaka and Shibata, Takako and Koike, Saaya and Hara, Masao and Hasegawa, Kiyotaka and Iino, Masato and Sonoki, Aska and Funasaka, Yoko},
  title = {Potassium 4‐Methoxysalicylate ( 4MSK ) Exerts a Skin Lightening Effect by Acting on Melanocytes and Keratinocytes},
  journal = {Journal of Cosmetic Dermatology},
  year = {2025},
  doi = {10.1111/jocd.70112}
}
Kostenlos starten →